Purification of hbv antigens for use in vaccines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

10344211

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for the production of a hepatitis B antigen suitable for use in a vaccine, the method comprising purification of the antigen in the presence of cysteine, to vaccines comprising such antigens.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE BIOLOGICALS (FORMERLY KNOWN AS SMITHKLINE BEECHAM BIOLOGICALS)RUE DE I'INSTITUT 89 B-1330 RIXENSART

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De-Heyder, Koen Rixensart, BE 4 4
Schu, Peter Rixensart, BE 3 3
Serantoni, Michelle Rixensart, BE 3 3
Van-Opstal, Omer Rixensart, BE 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation